Organization
Portola Pharmaceuticals, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Portola Pharmaceuticals, Inc.
... latest key findings for all current investors, traders, and shareholders of Portola Pharmaceuticals, Inc. (NASDAQ:PTLA), Kindred Healthcare, Inc. (NYSE:KND), Interface, Inc. (NASDAQ:TILE), Apogee Enterprises, Inc. ...
... SOUTH SAN FRANCISCO - Portola Pharmaceuticals, Inc. (Nasdaq: PTLA) today announced that the U.S. Food and Drug Administration (FDA) ...
... SOUTH SAN FRANCISCO - Portola Pharmaceuticals, Inc. (Nasdaq: PTLA) today announced that it will host an investor event to ...
... delayed consideration of AndexXa, a universal bleeding reversal agent being developed by Portola Pharmaceuticals. The South San Francisco, California, biotech told investors last week that ...
... SOUTH SAN FRANCISCO, Calif., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc.® (Nasdaq:PTLA) today announced that the U.S. Food and Drug Administration (FDA) ...
... SOUTH SAN FRANCISCO, Calif., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc.® (Nasdaq:PTLA) today announced that it will host an investor event to ...
... Portola Pharmaceuticals can go full throttle on its Bevyxxa launch, now that the ...
... members with timely information, WallStEquities.com has issued free tailored Stock Review on PTLA, SRPT, PACB, and BLUE which is a click away athttp://www.wallstequities.com/registration. Research coverage ...
... and full Prescribing Information, including the Boxed Warning at Bevyxxa.com About Portola Pharmaceuticals, Inc.Portola Pharmaceuticals is a biopharmaceutical company developing product candidates that could significantly ...
... South San Francisco, Calif., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc.® (Nasdaq:PTLA) today announced that the Committee for Medicinal Products for Human ...
... SOUTH SAN FRANCISCO, Calif., Dec. 05, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc.® (NASDAQ:PTLA) announced today that on November 27, 2017, the Compensation Committee ...
... and full Prescribing Information, including the Boxed Warning at Bevyxxa.com About Portola Pharmaceuticals, Inc.Portola Pharmaceuticals is a biopharmaceutical company developing product candidates that could significantly ...
... and full Prescribing Information, including the Boxed Warning at Bevyxxa.com About Portola Pharmaceuticals, Inc.Portola Pharmaceuticals is a biopharmaceutical company developing product candidates that could significantly ...
... as compared to traditional drugs. In addition, key market players such as Portola Pharmaceuticals (received FDA approval for its NOAC Betrixaban in July 2017) are ...
... as compared to traditional drugs. In addition, key market players such as Portola Pharmaceuticals (received the FDA approval for its NOAC-Betrixaban in July 2017) are ...
... SOUTH SAN FRANCISCO, Calif. - Portola Pharmaceuticals Inc. (Nasdaq: PTLA) today announced that results of new sub-analyses of the APEX ...
... SOUTH SAN FRANCISCO, Calif., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals Inc.® (Nasdaq:PTLA) will today report financial results and provide a corporate update ...
... as compared to traditional drugs. In addition, key market players such as Portola Pharmaceuticals (received the FDA approval for its NOAC Betrixaban in July 2017) ...
... SOUTH SAN FRANCISCO, Calif., Nov. 03, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals (Nasdaq:PTLA) today announced that Bill Lis, chief executive officer, will present at ...
... SOUTH SAN FRANCISCO, Calif., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc.® (Nasdaq:PTLA) today announced that it will host a webcast and conference ...
... Â 17Â The Priceline Group, Inc. (14) 1.3 % Â 18Â Portola Pharmaceuticals, Inc. (8) 1.3 % Â 19Â Ecolab, Inc. (13) 1.3 % Â ...
... SOUTH SAN FRANCISCO, Calif., Oct. 11, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals Inc.® (Nasdaq:PTLA) announced today that it will be serving as a global ...
... SOUTH SAN FRANCISCO, Calif., Oct. 03, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc.® (NASDAQ:PTLA) announced today that on September 27, 2017, the Compensation Committee ...
Want to see the full history on Portola Pharmaceuticals, Inc.? Upgrade to RelSci Pro now!
Start My Free Trial